Carity received regulatory and ethical approvals for a randomized controlled study which will be conducted at the University Hospital Zurich and the Cantonal Hospital St. Gallen. With the study approval, Carity is on its way to assess the clinical efficacy of its digital health intervention for cardiac rehabilitation patients.
With several million cardiac events, such as heart attacks, in Europe per year, cardiac rehabilitation is a critical component of the recovery journey for individuals who have faced heart-related health issues. Carity's innovative approach, offering a personalized digital support, comprehensive monitoring, and access to Personal Health Coaches, helps to bridge this gap by providing a comprehensive and holistic approach to cardiac rehabilitation, which combines digital and personal care. Carity is connected to validated wearable devices, enables patients’ psychocardiological monitoring and coaching.
The solution will now be tested in two prominent healthcare centers, the University Hospital Zurich (USZ) and the Cantonal Hospital St. Gallen (KSSG). Carity has received regulatory approval from Swissmedic and ethical approval from the Ethical Committee Zürich to commence its this randomized controlled study.
The study is set to include a total of 60 patients across Switzerland, divided into two distinct groups: a control group without the Carity digital intervention and an intervention group utilizing Carity's digital healthcare solution. The primary endpoint of the study is to evaluate the impact of Carity's digital healthcare solution on increasing physical activity among participants. In addition to the primary endpoint, the study will assess several secondary endpoints, including improvements in selected cardiopulmonary markers, psychological state, and quality of life of the participants. The research aims to provide comprehensive insights into how Carity's intervention positively influences the recovery journey of patients. The study is expected to include its initial patients before the end of 2023.
The study will be financed with funds from a pre-seed capital increase which Carity announced in June. The capital increase included a conversion of a convertible loan gathered in August 2022 and another with payment of cash proceeds. The two rounds are mostly supported by existing shareholders and added a few new Angels as new investors as well as the Startfeld Foundation in St. Gallen.
(Press release / SK)
Please login or sign up to comment.
Commenting guidelines